A common assumption is that peptide synthesis runs forward, adding the first amino acid of the sequence and working toward the last. In practice, solid-phase peptide synthesis does the opposite. The chain is built from the C-terminus back toward the N-terminus, and it is assembled while tethered to an insoluble support rather than floating free in solution. That single design choice explains almost everything about how the method works and where it goes wrong.
The resin bead that anchors everything
The support is a small polymer bead, typically a cross-linked polystyrene or a polyethylene-glycol-based resin, swollen in solvent so that reagents can diffuse into its interior. The very first amino acid is attached to this bead through a chemical linker at its carboxyl end. Everything that follows is built on top of that first residue while it stays fixed in place.
The advantage is purely practical. Because the growing chain is bound to something that will not dissolve, excess reagents and reaction byproducts can be washed away with solvent between every step. There is no need to purify an intermediate out of a mixture each time; you simply filter and rinse. The choice of linker also determines what the finished peptide looks like when it is finally released, whether it ends in a free acid or an amide, so the bead is not a passive scaffold but part of the chemistry.
How each amino acid gets coupled and locked in place
Adding a residue is a two-part rhythm repeated for the length of the sequence. First, the amino acid to be added is chemically activated at its carboxyl group so that it will readily form a bond. It is then introduced to the resin-bound chain, where its activated carboxyl reacts with the free amino group at the top of the growing peptide, forming the amide bond that links the two residues.
The trick that makes this controllable is protection. Every incoming amino acid carries a temporary protecting group on its own amino terminus, and reactive side chains carry their own protecting groups too. This ensures that the amino acid can only react at one point and cannot join to itself or to the wrong position. Coupling reagents drive the reaction toward completion, and the process is often run with an excess of amino acid to push as many chains as possible to react. Once coupling is done, the reagents are washed away and the chain waits for the next step.
Why deprotection steps decide whether the chain grows cleanly
After a residue is coupled, its temporary N-terminal protecting group is still in place, which means the chain cannot grow further until that group is removed. Deprotection strips it away and exposes a fresh amino group ready for the next coupling. This alternation of couple, deprotect, couple, deprotect is the engine of the whole synthesis.
The catch is that deprotection has to be nearly complete. If a fraction of the chains fail to lose their protecting group, those chains are effectively frozen and cannot accept the next amino acid. Overly harsh or prolonged deprotection can damage the peptide or prematurely remove side-chain protection. The window between too little and too much is where a great deal of a synthesis’s quality is quietly decided, and it is why careful process control matters as much as good reagents. Suppliers whose peptides you rely on for research, including outfits like Nuvia Peptides, depend on getting these repeated steps right hundreds of times over without accumulating error.
The truncations and deletions that end up in your final product
No coupling is perfectly efficient, and no deprotection is perfectly complete, so imperfections accumulate across a long sequence. When a chain fails to couple and its amino terminus is capped, or simply stalls, it becomes a truncated sequence, shorter than intended. When a single deprotection or coupling is skipped on some fraction of chains, the result is a deletion peptide missing one internal residue while otherwise looking almost identical to the target.
These related impurities are the reason a raw synthesis product is never pure. Because deletion sequences differ from the correct peptide by only a residue or two, they can be stubborn to separate during purification, and they are precisely what analytical methods like mass spectrometry and HPLC are meant to catch. The longer the sequence, the more chances there are for these errors to compound.
Understanding this makes one habit worth keeping: review the certificate of analysis and purity data for each batch you receive, rather than assuming the label alone tells the full story.